The Miami Project, at the University of Miami Miller School of Medicine, today announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord, in the February issue of the Journal of Neurotrauma. Schwann cells are essential for the repair of nerve damage, and long thought to be able to increase recovery after spinal cord injury. The trial, performed at University of Miami / Jackson Memorial Hospital in Miami, is the first in a series designed to evaluate the safety and feasibility of transplanting autologous human Schwann cells to treat individuals with spinal cord injuries. Continue Reading »
Browsing Articles by Date
One Saturday, as usual, I drove to the National Spinal Injury Hospital (NSIH). When I got there, I requested a gentleman, whom I later learnt was a brother to one of the patients, to help me get on my wheelchair. He was amazed!
“So you drive? And you cannot walk? Yet you’re such warm and joyful person,” he said to me.
“Oh, yes,” I replied, “And I was once a patient here, for seven months.”
His brother, just like me, was involved in a grisly road accident and suffered spinal cord injury. Like any other new-found friend he wanted to know more about me and my injury, and why it did not seem to be an issue. Continue Reading »